Tg(tetO-APPSwInd, KRT14-EGFP)#Dbo
Transgene Detail
|
Symbol: |
Tg(tetO-APPSwInd, KRT14-EGFP)#Dbo |
Name: |
transgene insertion, David R Borchelt |
MGI ID: |
MGI:7541105 |
Synonyms: |
moAPPsi-GFP |
Transgene: |
Tg(tetO-APPSwInd, KRT14-EGFP)#Dbo Location: unknown Genetic Position: ChrUN, Syntenic
|
Alliance: |
Tg(tetO-APPSwInd, KRT14-EGFP)#Dbo page
|
|
|
Transgene Type: |
|
Transgenic (Humanized sequence, Inserted expressed sequence, Reporter) |
Mutation: |
|
Insertion
|
|
|
Tg(tetO-APPSwInd, KRT14-EGFP)#Dbo expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
APP (351) |
|
mouse/human chimera with Swedish (KM570/571NL) and Indiana (V617F) mutations |
|
|
|
Mutation details: The mouse amyloid beta (A4) precursor protein (APP) sequence was modified to contain a humanized amyloid-beta (Abeta) domain. This mouse/human chimeric APP (mo/huAPP695 or APP695) was mutated to incorporate the Swedish (KM570/571NL) and Indiana (V617F) APP mutations associated with Alzheimer's disease. This APP695swe/ind sequence was placed downstream of the tetracycline-responsive (TRE or tetO) promoter and mouse prion protein exons 1-2.The transgene was co-integrated with a transgene in which the human KRT14 (K14) promoter drives skin-specific expression of EGFP.
(J:340366)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:340366 Xu G, et al., Murine Abeta over-production produces diffuse and compact Alzheimer-type amyloid deposits. Acta Neuropathol Commun. 2015 Nov 14;3:72 |
All: |
1 reference(s) |
|